William Weber

A Meta-Analysis of Cytokines in Major Depression

A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate

Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo

Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis

Glucocerebrosidase is shaking up the synucleinopathies

Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

Immunogenicity of Influenza Vaccination in Patients with Non-Hodgkin Lymphoma

Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease

Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis

Evolving concepts of rheumatoid arthritis

PPAR-γ agonists inhibit production of monocyte inflammatory cytokines

Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis

A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis

Non-motor features of Parkinson disease

2‐Chloroadenosine but not adenosine induces apoptosis in rheumatoid fibroblasts independently of cell surface adenosine receptor signalling

Anemia of Chronic Disease

Intracellular metabolite β-glucosylceramide is an endogenous Mincle ligand possessing immunostimulatory activity

DAMP-sensing receptors in sterile inflammation and inflammatory diseases

Relation between depression and circulating immune products in patients with advanced colorectal cancer

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein

Systemic Delivery of a Glucosylceramide Synthase Inhibitor Reduces CNS Substrates and Increases Lifespan in a Mouse Model of Type 2 Gaucher Disease

Increased Plasma Concentrations for Type I and II Tumor Necrosis Factor Receptors and IL-2 Receptors in Cancer Patients